Médi-2B
ActiveSummary
Médi-2B has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €221,118 and a net result of €8,967. Equity is growing by about 10% per year across the filed financial years. The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-07
Financial
Weakest financial yearnet €8,967 ▼26.4%
Net result drops to €8,967, the lowest in the series.
28-01
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-07
Financial
Equity above €200,000equity €212,152 ▲6.1%
A profit in every financial year since 2019 builds equity to €212,152.
29-01
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
30-01
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
28-01
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-07
Financial
Equity above €150,000equity €165,540 ▲26.5%
A profit in every financial year since 2019 builds equity to €165,540.
09-03
NBB filing
Annual accounts filed
financial year 2020 · micro format · 9 days late
2020
31-07
Financial
Liquidity more than triplescurrent ratio 4.84
Current ratio from 1.44 to 4.84; short-term debt falls from €72,868 to €19,139.
28-01
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
27-01
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
01-02
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
03-05
NBB filing
Annual accounts filed
financial year 2016 · full format · 64 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 13 annual accounts filed, the latest 10 are here; all 13 are under Financials.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.